Concepedia

Anna De Marco

AD

Statistics

Publications

8

Citations

2.9K

H-Index

8

Active since

2020

Affiliations

Vir Biotechnology (Switzerland)(Current)

University College London

University of Cambridge

Africa Health Research Institute

VIR Biotechnology (United States)

Anna De Marco is an author at Vir Biotechnology (Switzerland) specializing in infectious diseases, sars-cov-2 infection, and vaccinology.

Publications per year

2020–2022

8

Publications

8

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

Bo Meng, Adam Abdullahi, Isabella A.T.M. Ferreira et al. · Nature · 2022 · 1.2K citations · Full text

, , +17

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Dami A. Collier, Anna De Marco, Isabella A.T.M. Ferreira et al. · Nature · 2021 · 716 citations · Full text

, , +14

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7

Bo Meng, Steven A. Kemp, Guido Papa et al. · Cell Reports · 2021 · 452 citations · Full text

, , +17

Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70

Steven A. Kemp, Bo Meng, Isabella ATM Ferriera et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 224 citations · Full text

, , +17

SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies

Dami A. Collier, Anna De Marco, Isabella A.T.M. Ferreira et al. · medRxiv · 2021 · 167 citations · Full text

, , +15

1–5 of 8